Abstract
Two commercial identification systems were evaluated to determine if they could accurately identify NFB [glucose-nonfermenting gram-negative bacilli] isolated from animals. Of 182 strains of NFB, the MicroScan Urinary Combo Panel correctly identified 72%; the API 20E system correctly identified 74%. Of the 118 strains of the 3 most common species of NFB isolated from animals, the MicroScan Urinary Combo Panel identified 86% correctly; the API 20E system identified 92% correctly. The use of either of these systems could improve the accuracy of identification of NFB from clinical veterinary materials.